|
SOCS3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.822800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.553800E-01 |
| Normal-vs-Stage2 |
1.649370E-01 |
| Normal-vs-Stage3 |
1.862590E-01 |
| Normal-vs-Stage4 |
2.509400E-01 |
| Stage1-vs-Stage2 |
5.729400E-01 |
| Stage1-vs-Stage3 |
7.447800E-01 |
| Stage1-vs-Stage4 |
7.149400E-01 |
| Stage2-vs-Stage3 |
8.295000E-01 |
| Stage2-vs-Stage4 |
9.180400E-01 |
| Stage3-vs-Stage4 |
7.856000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.399600E-01 |
| Normal-vs-AfricanAmerican |
1.437220E-01 |
| Normal-vs-Asian |
7.858400E-01 |
| Caucasian-vs-AfricanAmerican |
7.234400E-01 |
| Caucasian-vs-Asian |
7.633800E-01 |
| AfricanAmerican-vs-Asian |
6.232400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.390180E-01 |
| Normal-vs-Female |
4.422600E-01 |
| Male-vs-Female |
3.482000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.113600E-02 |
| Normal-vs-Extreme_Weight |
4.396400E-01 |
| Normal-vs-Obese |
1.765620E-01 |
| Normal-vs-Extreme_Obese |
1.761620E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.496100E-02 |
| Normal_Weight-vs-Obese |
2.427200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.161200E-01 |
| Extreme_Weight-vs-Obese |
5.504400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.452000E-02 |
| Obese-vs-Extreme_Obese |
1.183040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.666600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.376370E-01 |
| Normal-vs-Age(61-80Yrs) |
2.111600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.398200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.750400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.707600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.989200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.900800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.313000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.392800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.291400E-01 |
| Normal-VS-Type2 PRCC |
6.891800E-02 |
| Normal-VS-KIRP CIMP |
4.408800E-01 |
| Normal-VS-Unclassified PRCC |
6.150200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.499200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.434630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.252400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.310100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.751200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.059570E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.207600E-01 |
| Normal-vs-N1 |
3.354800E-01 |
| Normal-vs-N2 |
7.281400E-01 |
| N0-vs-N1 |
6.556800E-01 |
| N0-vs-N2 |
2.740600E-01 |
| N1-vs-N2 |
3.251600E-01 |
|
|
